Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Haemonetics Corp. (HAE)
NYSE:HAE
Haemonetics (HAE) Stock Price & Analysis
309 Followers
HAE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$48.67 - $91.39
Previous Close$77.42
Volume316.84K
Average Volume (3M)410.27K
Market Cap
$3.91B
Enterprise Value$4.45B
Total Cash (Recent Filing)$224.00M
Total Debt (Recent Filing)$766.77M
Price to Earnings (P/E)41.6
Beta0.73
Next Earnings
May 09, 2023EPS Estimate
$0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.86
Shares Outstanding50,447,522
10 Day Avg. Volume497,465
30 Day Avg. Volume410,270
Standard Deviation0.12
R-Squared0.03
Alpha0.00890
Financial Highlights & Ratios
Price to Book (P/B)160.90
Price to Sales (P/S)3.63
Price to Cash Flow (P/CF)16.00
P/FCF Ratio32.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.94
Enterprise Value/Gross Profit8.80
Enterprise Value/Ebitda18.99
Forecast
1Y Price Target
$101.20Price Target Upside30.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Haemonetics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HAE FAQ
What was Haemonetics Corp.’s price range in the past 12 months?
Haemonetics Corp. lowest stock price was $48.67 and its highest was $91.39 in the past 12 months.
What is Haemonetics Corp.’s market cap?
Currently, no data Available
When is Haemonetics Corp.’s upcoming earnings report date?
Haemonetics Corp.’s upcoming earnings report date is May 09, 2023 which is in 44 days.
How were Haemonetics Corp.’s earnings last quarter?
Haemonetics Corp. released its earnings results on Feb 07, 2023. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.817 by $0.033.
Is Haemonetics Corp. overvalued?
According to Wall Street analysts Haemonetics Corp.’s price is currently Undervalued.
Does Haemonetics Corp. pay dividends?
Haemonetics Corp. does not currently pay dividends.
What is Haemonetics Corp.’s EPS estimate?
Haemonetics Corp.’s EPS estimate is $0.7.
How many shares outstanding does Haemonetics Corp. have?
Haemonetics Corp. has 50,447,520 shares outstanding.
What happened to Haemonetics Corp.’s price movement after its last earnings report?
Haemonetics Corp. reported an EPS of $0.85 in its last earnings report, beating expectations of $0.817. Following the earnings report the stock price went down -5.914%.
Which hedge fund is a major shareholder of Haemonetics Corp.?
Among the largest hedge funds holding Haemonetics Corp.’s share is Fisher Asset Management LLC. It holds Haemonetics Corp.’s shares valued at 87M.
---
Haemonetics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$101.20 (30.72% Upside)
$101.20 (30.72% Upside)
Blogger Sentiment
Bullish
HAE Sentiment 75%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 184.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 2.7%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.48%
12-Months-Change
Fundamentals
Return on Equity
12.71%
Trailing 12-Months
Asset Growth
2.55%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Haemonetics Corp.
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.
---
Top 5 ETFs holding HAE
Convergence Long/Short Equity ETF
$180.48K
Up to five ETFs with an Outperform Smart Score that hold HAE. The ETFs are listed according to market value of HAE within the ETF
---
---